Cosmos Health Inc [COSM] stock is trading at $0.80, up 16.33%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The COSM shares have gain 17.82% over the last week, with a monthly amount glided 4.09%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cosmos Health Inc [COSM] stock has fluctuated between $0.47 and $1.58 over the past year. Cosmos Health Inc [NASDAQ: COSM] shares were valued at $0.80 at the most recent close of the market.
Analyzing the COSM fundamentals
Cosmos Health Inc [NASDAQ:COSM] reported sales of 53.38M for the trailing twelve months, which represents a growth of 0.39%. Gross Profit Margin for this corporation currently stands at 0.08% with Operating Profit Margin at -0.36%, Pretax Profit Margin comes in at -0.36%, and Net Profit Margin reading is -0.36%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.59 and Total Capital is -0.51. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.32.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7332 points at the first support level, and at 0.6664 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8334, and for the 2nd resistance point, it is at 0.8668.
Ratios To Look Out For
For context, Cosmos Health Inc’s Current Ratio is 1.44. In addition, the Quick Ratio stands at 1.24 and the Cash Ratio stands at 0.13. Considering the valuation of this stock, the price to sales ratio is 0.35, the price to book ratio is 0.53.
Transactions by insiders
Recent insider trading involved Siokas Grigorios, Chief Executive Officer, that happened on Jan 14 ’25 when 87247.0 shares were purchased. Chief Executive Officer, Siokas Grigorios completed a deal on Jan 13 ’25 to buy 0.16 million shares. Meanwhile, Chief Financial Officer Terzis Georgios bought 85778.0 shares on Dec 20 ’24.
